Interferon-γ Therapy Reduces Blood Leukocyte Levels in Patients with Atopic Dermatitis: Correlation with Clinical Improvement

This publication has 44 references indexed in Scilit:

• Long-Term Therapy with Recombinant Interferon-Gamma (rIFN-γ) for Atopic Dermatitis
  Annals of Allergy, Asthma & Immunology, 1998
• Modulation of serum eosinophil cationic protein levels by cycosporin in severe atopic dermatitis
  British Journal of Dermatology, 1996
• Recombinant interferon gamma therapy for atopic dermatitis
  Journal of the American Academy of Dermatology, 1993
• IgE-Positive Langerhans Cells and TH2 Allergen-Specific T Cells in Atopic Dermatitis
  Journal of Investigative Dermatology, 1992
• Fcε receptor II/CD23+ lymphocytes in atopic dermatitis. III. Aberrant control in thein vitroexpression of FcεRII/CD23 on peripheral blood T cells in atopic dermatitis
  Clinical and Experimental Immunology, 1992
• Major histocompatibility complex class II hyperexpression on B cells in interleukin 4‐transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia
  European Journal of Immunology, 1991
• lnterleukin-4 Induced IgE and IgG4 Secretion by B Cells from Atopic Dermatitis Patients
  International Archives of Allergy and Immunology, 1991
• Elevated levels of soluble CD8 antigen in sera of patients with psoriasis ? a possible sign of suppressor/cytotoxic T-cell activation
  Archives of Dermatological Research, 1990
• Role of interleukins in induction and regulation of human IgE synthesis
  Clinical Immunology and Immunopathology, 1989
• Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.
  The Journal of Experimental Medicine, 1987